Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Scientists at Chulalongkorn University, Department of Biomedical Sciences discuss research in cancer gene therapy
May 13th, 2008
Scientists discuss in 'Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma' new findings in cancer gene therapy. According to a study from Bangkok, Thailand, "In search for putative tumor suppressor genes critical of nasopharyngeal carcinoma (NPC), we analyzed the available information from the expression profiling in conjunction with the comprehensive alleotyping published data relevant to this malignancy. Integration of this information suggested eight potential candidate tumor suppressor genes, CCNA1, HRASLS3, RARRES1, CLMN, EML1, TSC22, LOH11CR2A and MCC." "However, to confirm the above observations, we chose to investigate if...
Source: Cancer Weekly (2008-05-13)
|
